Lessons learned from COVID-19 vaccines could advance synthetic biology. Here’s how
Discussions about intellectual property waivers for COVID-19 vaccines are changing the course of scientific research. The field of synthetic biology could harness this moment to enable a more democratic distribution of tools and technologies. Low and middle income countries can equitably participate in the development and use of these technologies. Recent debates around how intellectual […]
